Jump to Navigation

User login

Facebook Connect

CME Activity: Reducing CVD Risk in the Patient with High Triglycerides and Metabolic Syndrome or DM2

Presented by:

              

Activity Overview

This online activity is based on Reducing CVD Risk in the Patient with High Triglycerides and Metabolic Syndrome or DM-2: You Be the JudgeTM held on June 1, 2012 in Scottsdale, AZ.

Selected faculty presentations (audio and slides) include

  • What Is the Relationship of Hypertriglyceridemia and Low HDL-C to the Increased CVD Risk in Metabolic Syndrome and DM-2?
  • What Tests Should We Order to Define CVD Risk in the HTG + MetS/DM-2 Patient?
  • What Is the Best Current Lipid Management in the HTG + MetS/DM-2 Patient?
  • What Agents Are in Development for Management of HTG?

Target Audience

This activity is designed for cardiologists, internists, lipidologists, and other healthcare professionals involved in the treatment of patients at risk of cardiac events.

Faculty

Harold E. Bays, MD
Medical Director and President
Louisville Metabolic and Atherosclerosis Research Center Inc.
Louisville, KY

Eliot A. Brinton, MD
Vice President, American Board of Clinical Lipidology
President, Utah Atherosclerosis Society
President, Utah Lipid Center
Director of Atherometabolic Research
Utah Foundation for Biomedical Research
Salt Lake City, UT

W. Virgil Brown, MD
Professor Emeritus, Medicine
Emory University School of Medicine
Atlanta, GA

Terry A. Jacobson, MD
Professor of Medicine
Director, Office of Health Promotion and Disease Prevention
Emory University
Co-Director, Lipid and Cardiovascular Risk Reduction Program
Grady Health Systems
Atlanta, GA

Accreditation Information

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Content Domain
This activity falls under the following content domain(s):

  • 1.2.6 Fatty Acid and Triglyceride Metabolism
  • 5.4.1.3 Type 2 diabetes mellitus
  • 8.9 Dyslipidemia Management in Metabolic Syndrome and Obesity

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Affect the management of patients with hypertriglyceridemia in patients with metabolic syndrome or type 2 diabetes mellitus using guideline recommendations and evidence-based treatment
  2. Assess the potential of new and emerging therapeutic approaches to manage hypertriglyceridemic states
  3. Describe the relationship of atherogenic lipids in the setting of mixed dyslipidemia in patients with metabolic syndrome or type 2 diabetes mellitus
  4. Provide appropriate care and counsel for patients and their families. (For Registered Nurses and Nurse Practitioners only)



by Dr. Radut.